Cancer Tissue Diagnostics market in Europe is expected to grow from US$ 512.73 Mn in the year 2018 and is expected to reach US$ 830.28 Mn by 2027 growing at a CAGR of 5.8% over the forecast period.
The growth of the market is driven by the factors such as increasing number of cancer cases and rising geriatric population. On the other hand, high cost of cancer diagnostics in some of the European countries is limiting the growth of market is likely to have a negative impact on the growth of the market in the coming years.
Get Sample PDF of this Report @ https://www.theinsightpartners.com/sample/TIPRE00006840/
Companies Mentioned
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Abbott
- Enzo Life Sciences, Inc.
- Agilent Technologies, Inc.
- Cancer Genetics Inc.
- Merck KGaA (Sigma-Aldrich Co. LLC)
- Danaher
- Abcam plc.
Cancer is among the leading cause of deaths across Europe globe and is profoundly affecting the quality of life. Thus, cancer will be a burden on society if not diagnosed and treated on time. According to the World Health Organization in 2018, approximately 9.6 million deaths across the globe were due to cancer. Additionally, cancer is found to be commonly prevalent in European countries as well. As per the Cancer Research UK, in 2016, around 163,444 deaths in the UK were due to cancer.
Ask For Discount @ https://www.theinsightpartners.com/discount/TIPRE00006840/
The World Health Organization (WHO) also reported that with over 3.7 million new cases and 1.9 million deaths each year, cancer is the second most important cause of morbidity and death in Europe. Moreover, Europe comprises of one-eighth of the total world population, however approximately a quarter of global cancer cases with 3.7 million new patients are from Europe, suggesting high incidence rate of cancer in the region. Furthermore, the data also suggests that 40% of these cancer cases are preventable with appropriate diagnosis at early stages and correct treatment and medication.
The Spain Cancer Tissue Diagnostics market is expected to grow at highest rate during the forecast period owing to various cancer research studies undergoing in the country, increasing number of cancer patients in the country, and various solutions undertaken to reduce the financial burden due to cancer on the country.
Purchase this Report @ https://www.theinsightpartners.com/buy/TIPRE00006840/
TABLE OF CONTENTS
1. Introduction
1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
2. Europe Cancer Tissue Diagnostics Market – Key Takeaways
3. Europe Cancer Tissue Diagnostics Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Europe Cancer Tissue Diagnostics Market – By Test Type
3.2.2 Europe Cancer Tissue Diagnostics Market – By Country
3.3 PEST Analysis
3.3.1 Europe – PEST Analysis
4. Europe Cancer Tissue Diagnostics Market – Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Number of Cancer Cases
4.1.2 Increasing Geriatric Population
4.2 Key Market Restraint
4.2.1 High Cost of Cancer Diagnostics
4.3 Key Market Opportunities
4.3.1 Rising Healthcare Expenditure in Europe
4.4 Future Trends
4.4.1 Adoption of Personalized Medicine
4.5 Impact Analysis
5. Cancer Tissue Diagnostics Market – Europe Analysis
5.1 Europe Cancer Tissue Diagnostics Market Revenue Forecasts And Analysis
5.2 Performance Of Key Players
5.3 Positioning of Key Players
Contact Us:
Call: +1-646-491-9876
Email: [email protected]
